ReviewCurrent pharmaceutical design2026
New Standards in the Treatment of Advanced Metastatic Melanoma: Immunotherapy and BRAF-Targeted Therapies as Emerging Paradigms.
Firas Kreidieh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it